Product Information

PROPRANOLOL ER 120 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $0.2096 per EA under NDC 00527411837. Its NADAC has been published 305 times since Jan 20, 2021.

FDA first approved this application on Jan 6, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PROPRANOLOL ER 120 MG CAPSULE

propranolol hydrochloride
$0.2096per EA

Strength

120 mg/1

NDC

00527411837

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PROPRANOLOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212026

FDA Approved

1/6/2020

TE Code

AB

On Market Since

1/6/2020

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for PROPRANOLOL ER 120 MG CAPSULE has been published 305 times since Jan 20, 2021, and over the history we have for it it has declined 58.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2096 per EA
All-time high$0.6028 (Mar 10, 2021)
All-time low$0.1620 (May 22, 2024)
52-week high$0.2096
52-week low$0.1858
Median price$0.2207
Average price$0.2771
Largest weekly change-32.4% (Jul 20, 2022)
Weeks tracked305
Tracking sinceJan 20, 2021

Price History

1W

+1.7%

1M

+1.7%

3M

+9.2%

6M

+8.5%

1Y

+4.8%

3Y

+5.1%

5Y

-51.9%

All

-58.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PROPRANOLOL ER 120 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PROPRANOLOL ER 120 MG CAPSULE, manufactured by Lannett Company Inc., is $0.2096 per EA (NDC 00527411837), effective Nov 18, 2026.

How has the price of PROPRANOLOL ER 120 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PROPRANOLOL ER 120 MG CAPSULE has declined 58.5%. It has been tracked across 305 weekly CMS publications since Jan 20, 2021.

What are the highest and lowest recorded NADAC prices for PROPRANOLOL ER 120 MG CAPSULE?

Since Jan 20, 2021, the NADAC for PROPRANOLOL ER 120 MG CAPSULE has ranged from a low of $0.1620 (May 22, 2024) to a high of $0.6028 (Mar 10, 2021), with a median of $0.2207 per EA.

Are there cheaper alternatives to PROPRANOLOL ER 120 MG CAPSULE?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROPRANOLOL ER 120 MG CAPSULE, is $0.1839 per EA — about 12% below PROPRANOLOL ER 120 MG CAPSULE.

Who manufactures PROPRANOLOL ER 120 MG CAPSULE?

PROPRANOLOL ER 120 MG CAPSULE (NDC 00527411837) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.